Macaque-tropic human immunodeficiency virus type 1: breaking out of the host restriction factors

Akatsuki Saito1, Hirofumi Akari

  • 1Center for Human Evolution Modeling Research, Primate Research Institute, Kyoto University Inuyama, Japan ; Japan Foundation for AIDS Prevention Chiyoda-ku, Japan.

Insights

Researchers developed macaque-tropic human immunodeficiency virus type 1 (HIV-1mt) for better vaccine and drug testing. This breakthrough overcomes host restriction factors, enabling efficient HIV-1 replication in macaques.

Area of Science:

  • Virology
  • Immunology
  • Primatology

Background:

  • Macaque models are crucial for lentiviral infection studies.
  • Human immunodeficiency virus type 1 (HIV-1) poorly replicates in macaques, limiting research.
  • Simian immunodeficiency virus (SIV) and SHIV are used but are genetically distant from HIV-1.

Purpose of the Study:

  • To develop a macaque-tropic HIV-1 (HIV-1mt) for efficient replication in macaques.
  • To enable better evaluation of anti-HIV-1 drugs and vaccines in macaque models.
  • To investigate host factors influencing macaque susceptibility to HIV-1mt.

Main Methods:

  • Overcoming host restriction factors like APOBEC3 and TRIM5.
  • Developing genetically modified HIV-1 strains (HIV-1mt) for macaque tropism.
  • Analyzing host-pathogen interactions in macaque lentiviral infection models.

Main Results:

  • Successfully created an HIV-1mt capable of efficient replication in macaques.
  • Demonstrated that evasion of host restriction factors is key to macaque tropism.
  • Identified TRIM5-related factors as significant in macaque susceptibility to HIV-1mt.

Conclusions:

  • The developed HIV-1mt is a valuable tool for preclinical studies of HIV-1 therapies.
  • Understanding host restriction factors like TRIM5 is critical for lentiviral vector development.
  • This advancement facilitates more accurate assessment of HIV-1 interventions in a relevant animal model.

Related Concept Videos